Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
1779 |
|
Actual shortage: | 173 (10%) | |
Anticipated shortage: | 4 (0%) | |
Avoided shortage: | 7 (0%) | |
Resolved: | 1595 (90%) | |
Discontinuation Reports |
343 |
|
To be discontinued: | 21 (6%) | |
Discontinued: | 322 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
120 (6%) |
|
Overdue reports |
22 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO METHAZIDE 25 | 25MG 250MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18936 |
APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2020-10-28 | 2020-11-09 | 127363 |
APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132358 |
APO-METOPROLOL | 100MG | TABLET | Resolved | 2020-05-08 | 2020-07-20 | 114300 |
APO-METOPROLOL | 100MG | TABLET | Resolved | 2020-08-06 | 2020-11-09 | 121906 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2017-07-25 | 2017-09-22 | 16879 |
APO-NAPROXEN | 500MG | TABLET | Avoided shortage | 2017-07-25 | 2017-11-09 | 16881 |
APO OXAZEPAM TAB 10MG | 10MG | TABLET | Resolved | 2018-04-16 | 2018-07-03 | 46027 |
APO OXAZEPAM TAB 15MG | 15MG | TABLET | Resolved | 2018-03-20 | 2018-07-03 | 43516 |
APO OXAZEPAM TAB 30MG | 30MG | TABLET | Resolved | 2018-05-08 | 2018-07-03 | 48846 |
APO OXAZEPAM TAB 30MG | 30MG | TABLET | Resolved | 2018-12-12 | 2019-01-28 | 69455 |
APO OXTRIPHYLLINE TAB 100MG | 100MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18939 |
APO OXTRIPHYLLINE TAB 200MG | 200MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18942 |
APO OXTRIPHYLLINE TAB 300MG | 300MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18954 |
APO PEN VK | 200000UNIT | POWDER FOR SOLUTION | Resolved | 2017-03-11 | 2019-03-09 | 429 |
APO PEN VK | 480000UNIT | POWDER FOR SOLUTION | Resolved | 2017-03-11 | 2019-03-08 | 432 |
APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2018-03-05 | 2018-10-30 | 41862 |
APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-04-15 | 131883 |
APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2017-06-13 | 2017-07-31 | 12692 |
APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2018-05-15 | 2018-08-31 | 49506 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 |